| GTF2B |
GTF2B, TF2B, TFIIB: Transcription initiation factor IIB |
EIF3S2 |
EIF3S2, TRIP1: Eukaryotic translation initiation factor 3 subunit 2 |
2.525 |
Evidence |
O
|
| ETF1 |
ETF1, ERF1, RF1, SUP45L1: Eukaryotic peptide chain release factor subunit 1 |
ATR |
ATR, FRP1: Serine/threonine-protein kinase ATR |
2.525 |
Evidence |
|
| NHP2L1 |
NHP2L1: NHP2-like protein 1 |
USP7 |
USP7, HAUSP: Ubiquitin carboxyl-terminal hydrolase 7 |
2.525 |
Evidence |
|
| OSBP |
OSBP, OSBP1: Oxysterol-binding protein 1 |
ETF1 |
ETF1, ERF1, RF1, SUP45L1: Eukaryotic peptide chain release factor subunit 1 |
2.525 |
Evidence |
|
| MTHFD1 |
MTHFD1, MTHFC, MTHFD: C-1-tetrahydrofolate synthase, cytoplasmic |
RPL8 |
RPL8: 60S ribosomal protein L8 |
2.525 |
Evidence |
|
| AURKA |
AURKA, AIK, ARK1, AURA, BTAK, STK15, STK6: Serine/threonine-protein kinase 6 |
KPNB1 |
KPNB1, NTF97: Importin subunit beta-1 |
2.525 |
Evidence |
|
| DSTN |
DSTN, ACTDP, DSN: Destrin |
PDLIM5 |
PDLIM5, ENH: PDZ and LIM domain protein 5 |
2.522 |
Evidence |
|
| EIF3S4 |
EIF3S4: Eukaryotic translation initiation factor 3 subunit 4 |
LSM5 |
LSM5: U6 snRNA-associated Sm-like protein LSm5 |
2.522 |
Evidence |
|
| SF3B1 |
SF3B1, SAP155: Splicing factor 3B subunit 1 |
LSM5 |
LSM5: U6 snRNA-associated Sm-like protein LSm5 |
2.522 |
Evidence |
|
| HGS |
HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate |
LSM5 |
LSM5: U6 snRNA-associated Sm-like protein LSm5 |
2.522 |
Evidence |
|
| HGS |
HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate |
LSM8 |
LSM8: U6 snRNA-associated Sm-like protein LSm8 |
2.522 |
Evidence |
|
| FYN |
IPI00640091 |
MATK |
DKFZp434N1212, MATK, hCG_23522: Putative uncharacterized protein DKFZp434N1212 |
2.52 |
Evidence |
|
| JAK1 |
|
MATK |
DKFZp434N1212, MATK, hCG_23522: Putative uncharacterized protein DKFZp434N1212 |
2.52 |
Evidence |
|
| JAK1 |
|
FYN |
IPI00640091 |
2.52 |
Evidence |
|
| HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
HLA-DRB5 |
HLA-Dw12: Cell surface glycoprotein |
2.52 |
Evidence |
|
| TAPBPL |
TAPBPL: Tapasin-related protein precursor |
HLA-E |
HLA-E, XXbac-BPG34K20.2-001: MHC class Ib antigen |
2.52 |
Evidence |
|
| OLIG2 |
OLIG2, BHLHB1, PRKCBP2, RACK17: Oligodendrocyte transcription factor 2 |
ARNT2 |
ARNT2, KIAA0307: Aryl hydrocarbon receptor nuclear translocator 2 |
2.52 |
Evidence |
|
| BIRC1 |
BIRC1, NAIP: Baculoviral IAP repeat-containing protein 1 |
CARD15 |
NOD2, CARD15, IBD1: Nucleotide-binding oligomerization domain-containing protein |
2.52 |
Evidence |
|
| B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
HLA-E |
HLA-E, XXbac-BPG34K20.2-001: MHC class Ib antigen |
2.52 |
Evidence |
|
| ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
MATK |
DKFZp434N1212, MATK, hCG_23522: Putative uncharacterized protein DKFZp434N1212 |
2.52 |
Evidence |
|
| ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
FYN |
IPI00640091 |
2.52 |
Evidence |
O
|
| HLA-F |
HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec |
TAPBPL |
TAPBPL: Tapasin-related protein precursor |
2.52 |
Evidence |
|
| HLA-F |
HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
2.52 |
Evidence |
O
|
| PSMA1 |
PSMA1, PROS30, PSC2: Proteasome subunit alpha type-1 |
PSMA3 |
PSMA3, PSC8: Proteasome subunit alpha type-3 |
2.52 |
Evidence |
|
| PSMA1 |
PSMA1, PROS30, PSC2: Proteasome subunit alpha type-1 |
PSMB7 |
PSMB7: Proteasome subunit beta type-7 precursor |
2.52 |
Evidence |
|